XAGE Valuation
Longevity Health Holdings, Inc.
$
0.159
- Overview
- Forecast
- Valuation
XAGE Relative Valuation
XAGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XAGE is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.90
P/B
Median3y
-0.91
Median5y
-0.91
-116.95
FCF Yield
Median3y
-106.55
Median5y
-106.55
Competitors Valuation Multiple
The average P/S ratio for XAGE's competitors is 0.26, providing a benchmark for relative valuation. Longevity Health Holdings, Inc. Corp (XAGE) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
People Also Watch
ARKO
Arko Corp.
3.980
USD
0.00%
CPF
Central Pacific Financial Corp
24.920
USD
+0.32%
CFFN
Capitol Federal Financial Inc
5.230
USD
+0.58%
MLAB
Mesa Laboratories Inc
112.920
USD
-2.25%
MTAL
Metals Acquisition Ltd
8.780
USD
+2.45%
TCPC
BlackRock TCP Capital Corp
6.640
USD
-0.75%
LAC
Lithium Americas Corp
2.700
USD
+2.66%
MEG
Montrose Environmental Group Inc
14.260
USD
+0.49%
BFST
Business First Bancshares Inc
22.440
USD
+0.99%
PLYM
Plymouth Industrial REIT Inc
14.310
USD
+1.13%
FAQ
Is Longevity Health Holdings, Inc. (XAGE) currently overvalued or undervalued?
Longevity Health Holdings, Inc. (XAGE) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Longevity Health Holdings, Inc. (XAGE) is between to according to relative valuation methord.
What is Longevity Health Holdings, Inc. (XAGE) fair value?
How does XAGE's valuation metrics compare to the industry average?
What is the current P/B ratio for Longevity Health Holdings, Inc. (XAGE) as of Apr 16 2025?
What is the current FCF Yield for Longevity Health Holdings, Inc. (XAGE) as of Apr 16 2025?
What is the current Forward P/E ratio for Longevity Health Holdings, Inc. (XAGE) as of Apr 16 2025?